NEW YORK (GenomeWeb News) - WellGen has taken in $9.5 million in a Series C round of venture-capital financing from new and existing shareholders, the company said Monday.
The nutrigenomics company said it plans to use the cash to hire new personnel and expand its "molecular biology and natural products chemistry laboratory."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.